The synthetic FXR agonist PX20606 attenuates bacterial translocation, intestinal inflammation, and reduces splanchnic blood flow in portal hypertensive mice

BA Payer; Philipp Schwabl; Matias Wagner; L Garnys; Florian Riedl; TL Schubert; Michael Trauner; Markus Peck‐Radosavljevic; Thomas Reiberger

doi:10.1055/s-0034-1376035

The synthetic FXR agonist PX20606 attenuates bacterial translocation, intestinal inflammation, and reduces splanchnic blood flow in portal hypertensive mice

Identifier:nobleid.org/w1/20260515/08FC403E

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/08FC403E.svg?ark=w1%2F20260515%2F08FC403E)](https://nobleid.org/work/w1/20260515/08FC403E)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Markus Peck‐Radosavljevic

Thomas Reiberger

Claim authorship of this work

The synthetic FXR agonist PX20606 attenuates bacterial translocation, intestinal inflammation, and reduces splanchnic blood flow in portal hypertensive mice

Identifier:nobleid.org/w1/20260515/08FC403E

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/08FC403E.svg?ark=w1%2F20260515%2F08FC403E)](https://nobleid.org/work/w1/20260515/08FC403E)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Markus Peck‐Radosavljevic

Thomas Reiberger

Claim authorship of this work